Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 CAD | +0.61% | -5.14% | -50.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.45% | 19.01M | |
+4.09% | 43.84B | |
+46.34% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences : Says Luxeptinib Treatment Shows Clinical Activity in Phase 1 A/B Trials for Acute Myeloid Leukemia, B Cell Malignancies